Brief: MedinCell H1 Net Financial Loss At 2.1 Million Euros

Medincell SA

06/12/2022 17:45

Dec 6 (Reuters) - Medincell SA  MEDCL.PA :
    * H1 REVENUE: EUR 7.7 MILLION (+89% COMPARED TO FIRST HALF
OF
PREVIOUS YEAR)
    * H1 OPERATING EXPENSES: €19.4 MILLION (+27% COMPARED TO THE
FIRST
HALF OF THE PREVIOUS YEAR)
    * CASH CONSUMPTION FROM OPERATIONS: EUR 10 MILLION
    * AVAILABLE CASH: €11.7 MILLION IN CASH AND CASH EQUIVALENT
+ €2.5
MILLION IN NON-RISKY CURRENT FINANCIAL ASSETS IN SEPTEMBER 30,
2022
    * EXPECTED CASH INFLOWS OF MORE THAN EUR 29 MILLION BY END
OF
FIRST SEMESTER 2023 AND REVISION OF INVESTMENT PLAN
    * SUBSTANTIAL MILESTONES PLANNED IN 2023 FOR MDC-KPT (ANIMAL
HEALTH) AND MDC-TTG (COVID-19) COULD ENABLE TO ENGAGE PARTNERS
TO PURSUE THEIR DEVELOPMENT
    * H1 NET FINANCIAL INCOME: EUR -2.1 MILLION

Source text for Eikon:  ID:nBw2lCLlKa 
Further company coverage:  MEDCL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))